Results 21 to 30 of about 3,795,370 (153)

Essential medicines in Tanzania : does the new delivery system improve supply and accountability? [PDF]

open access: yes, 2013
Objective: Assess whether reform in the Tanzanian medicines delivery system from a central 'push' kit system to a decentralized 'pull' Integrated Logistics System (ILS) has improved medicines accountability.
Graham Reid   +17 more
core   +2 more sources

Towards a Patent Pool for HIV Medicines: The Background [PDF]

open access: yes, 2010
Recent WHO guidelines for antiretroviral therapy recommend switching to less toxic, but more expensive medicines for first-line and second-line ART, raising questions about the financial sustainability of many AIDS treatment programmes. At the same time,
Childs, Michelle
core   +1 more source

Implementation of health technology assessment at the stage of market access for pharmaceuticals in Ukraine

open access: yesФармацевтичний журнал, 2020
Market access for pharmaceuticals is a set of strategies, activities and processes developed by pharmaceutical companies to provide affordable medicines at appropriate fair prices in a particular health care system.
O. B. Piniazhko   +5 more
doaj   +1 more source

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list

open access: yesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2022
Background: Tuberculosis (TB) remains a major cause of morbidity and mortality globally despite effective treatments. Along with high-quality health services, essential medicines are a key tool in curbing TB related mortality.
Darshanand Maraj   +2 more
doaj   +1 more source

Driving a decade of change: HIV/AIDS, patents and access to medicines for all [PDF]

open access: yes, 2011
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to reach more than five million people in developing countries.
Moon, Suerie   +11 more
core   +1 more source

A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries [PDF]

open access: yes, 2011
Background: Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as ...
Childs, Michelle   +11 more
core   +1 more source

Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014 [PDF]

open access: yes, 2019
Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited.
Mallol, J   +543 more
core   +3 more sources

In-hospital safety in field conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. B. Gambiense Sleeping Sickness [PDF]

open access: yes, 2012
Trypanosoma brucei (T.b.) gambiense Human African trypanosomiasis (HAT; sleeping sickness) is a fatal disease. Until 2009, available treatments for 2(nd) stage HAT were complicated to use, expensive (eflornithine monotherapy), or toxic, and ...
Kisala, M   +74 more
core   +1 more source

Improving antibiotic prescribing for children in the resource-poor setting. [PDF]

open access: yes, 2015
Antibiotics are a critically important part of paediatric medical care in low- and middle-income countries (LMICs), where infectious diseases are the leading cause of child mortality. The World Health Organization estimates that >50% of all medicines are
Le Doare, Kirsty   +7 more
core   +1 more source

Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE [PDF]

open access: yes, 2022
BACKGROUND: Shortages and unequal access to anticancer medicines for children and adolescents are a reality in Europe. The aim of the European Society for Paediatric Oncology (SIOPE) Essential Anticancer Medicines Project was to provide a list of ...
Otth, Maria; https://orcid.org/   +91 more
core   +2 more sources

Home - About - Disclaimer - Privacy